Laser Lead Extraction in Congenital Heart Disease: A Case-Controlled Study

2013 ◽  
Vol 36 (3) ◽  
pp. 372-380 ◽  
Author(s):  
ANTHONY C. McCANTA ◽  
MELISSA H. KONG ◽  
MICHAEL P. CARBONI ◽  
RUTH A. GREENFIELD ◽  
PATRICK M. HRANITZKY ◽  
...  
2007 ◽  
Vol 18 (5) ◽  
pp. 507-511 ◽  
Author(s):  
PAUL KHAIRY ◽  
JEAN-FRANÇOIS ROUX ◽  
MARC DUBUC ◽  
BERNARD THIBAULT ◽  
PETER G. GUERRA ◽  
...  

1996 ◽  
Vol 19 (5) ◽  
pp. 778-783 ◽  
Author(s):  
RICHARD A.FRIEDMAN ◽  
HEIDI ZANDT ◽  
ELIZABETH COLLINS ◽  
MARC LEGRAS ◽  
JAMES PERRY

2019 ◽  
Vol 47 (4) ◽  
pp. 1677-1684 ◽  
Author(s):  
Jin Gong ◽  
Rufang Zhang ◽  
Li Shen ◽  
Yewei Xie ◽  
Xiaobing Li

Objective To study the brain protective effect of dexmedetomidine (DEX) during surgery in paediatric patients with congenital heart disease (CHD). Methods This randomized single-blind controlled study enrolled paediatric patients aged 0–3 years with CHD who underwent surgery and randomized them into two groups: one group received DEX and the control group received 0.9% NaCl during anaesthesia. Demographic data, heart rate (HR), mean arterial pressure (MAP) and central venous pressure (CVP) were recorded. Levels of neuron specific enolase (NES) and S-100β protein were determined using enzyme-linked immunosorbent assays. Results The study enrolled 80 paediatric patients with CHD. Compared with the control group, HR, MAP and CVP were significantly lower in the DEX group at all time-points except for T0. At all time-points except for T0, the levels of jugular venous oxygen saturation in the DEX group were significantly higher compared with the control group. At all time-points except for T0, the levels of arterial venous difference and cerebral extraction of oxygen were significantly lower in the DEX group compared with the control group. Levels of NES and S-100β protein in the DEX group were significantly lower compared with the control group at all time-points except for T0. Conclusion DEX treatment during surgery for CHD improved oxygen metabolism in brain tissues and reduced the levels of NES and S-100β protein.


QJM ◽  
2021 ◽  
Vol 114 (Supplement_1) ◽  
Author(s):  
Alyaa A Kotby ◽  
Waleed M El Guindy ◽  
Deena Samir M Eissa ◽  
Abeer Mohammed H Hussain

Abstract Background Down syndrome (DS), the most common chromosomal abnormality is associated by congenital heart disease (CHD) in (44%) of cases. Children with DS might have different growth pattern compared to children without DS. Objective To assess the impact of congenital heart disease on the growth of Down syndrome children who attend the Genetic clinic, Children’s Hospital, Ain Shams University. Materials and Methods This case controlled study was conducted on 40 children with DS aged 6-36 months and compared to 40 age and sex matched healthy children. The DS children were divided in to two groups, the Cardiac Group: Included 20 DS children with CHD, Non Cardiac Group: 20 DS children without CHD. All children enrolled in the study were subjected to detailed history, thorough clinical examination including (anthropometric measurements (weight, height and HC) and cardiac examination. Results A statistically highly significant decrease was found in children with DS in comparison to normal children in all evaluated anthropometric measurements (P = 0.000) for weight, height, WT/length SDS, head circumference and Z-scores (weight, height and HC).A statistically highly significant decrease was found in DS children with congenital heart disease (cardiac group) in comparison with DS children without congenital heart disease (non-cardiac group) as regards weight (P = 0.002), Height (P = 0.000), head circumference (P = 0.000), Zscores (weight) (P = 0.001) and WT/length SDS (P = 0.001). Conclusion Children with trisomy 21 have well documented growth retardation. Congenital heart diseases have a negative influence on growth pattern in children with DS.


Circulation ◽  
2008 ◽  
Vol 118 (suppl_18) ◽  
Author(s):  
Joseph Atallah ◽  
Charles I Berul ◽  
Mark E Alexander ◽  
John K Triedman ◽  
Edward P Walsh ◽  
...  

Background: Transvenous pacemaker and defibrillator device implant is a rapidly growing practice in pediatric and young adult congenital heart disease. The need for lead extraction is an associated eventuality in certain patients. Although several techniques have emerged in the past few years, the safety and efficacy of lead extraction in the pediatric population remains unknown. We report our experience with lead extraction using simple traction or complex extraction methods. Methods: Retrospective cohort study of all patients having undergone a lead extraction at Children’s Hospital Boston from 2002 to 2008. Lead extraction was defined as simple if only traction was required and complex if it required the use of an interlocking stylet. Results: A total of 114 patients underwent 124 lead extraction procedures with a total of 172 extraction attempts. The average age was 17.1 (2.47– 48.23) years at lead implant and 23.0 (6 –52.7) years at lead extraction. Congenital heart disease was present in 57.3% (71/124) of patients. Extraction by simple traction was achieved for 51 leads (mean lead age=3.1 years), while the remaining 121 leads required complex extraction (mean lead age=7.5 years), of which 32 were abandoned. Of the remaining leads 83/89 (93%) were extracted successfully. Only 2/55 (4%) leads >7.5 years of age could be extracted with simple traction. However, 63/99 (64%) leads >1 and <7.5 years of age were a complex extraction. Multivariable logistic regression analysis showed that a younger lead age (OR=0.7, 95% CI 0.6 – 0.9, P<0.01), silicone-type of lead insulation (OR=7.6, 95% CI 1.6 –36.7, P=0.01) and a lead in the atrial position (OR=3.0, 95% CI 1.1– 8.7, P=0.05) were independent predictors of a simple extraction. There was only one major complication consisting of right atrial perforation and tamponade that was controlled with surgical exploration. There was no mortality related to lead extraction procedures. Conclusion: The majority of leads implanted in pediatric and young adult patients with congenital heart disease can be extracted successfully. Though certain lead characteristics correlated with a simple extraction procedure, the majority of leads >1 year of age will require a complex extraction technique.


EP Europace ◽  
2016 ◽  
pp. euw049 ◽  
Author(s):  
Erin A. Fender ◽  
Ammar M. Killu ◽  
Bryan C. Cannon ◽  
Paul A. Friedman ◽  
Christopher J. Mcleod ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document